✦ LIBER ✦

Feasibility of high-dose hyperfractionated re-irradiation in patient with recurrent or second head and neck tumors

✍ Scribed by S. Appold; Th. Herrmann; M. Baumann

Book ID: 119518165
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 120 KB
Volume: 82
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(07)80059-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re-irradiation with scanned charged part

Re-irradiation with scanned charged particle beams in recurrent tumours of the head and neck: Acute toxicity and feasibility

✍ Alexandra D. Jensen; Anna Nikoghosyan; Malte Ellerbrock; Swantje Ecker; Jürgen D 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 344 KB

Re-irradiation for Second Primary or Rec

Re-irradiation for Second Primary or Recurrent Cancers of the Head and Neck: Composite Dosimetric Measures to Evaluate Dose to the Carotid Arteries

✍ Garg, S.; Kilburn, J.M.; Randolph, D.M.; Lucas, J.T.; Urbanic, J.J.; Porosnicu, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Phase I trial and pharmacokinetics of es

Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma

✍ Philip C. Amrein; John R. Clark; Jeffrey G. Supko; Richard L. Fabian; Chiu C. Wa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

## Abstract ## BACKGROUND Amifostine was developed to protect normal tissues from radiation exposure. The current study was undertaken to determine whether amifostine would allow the delivery of greater numbers of weekly paclitaxel treatments with concomitant, hyperfractionated radiotherapy in pat

19 oral Interstitial pulsed-dose-rate br

19 oral Interstitial pulsed-dose-rate brachytherapy in the management of patients with head and neck tumors in previously irradiated area

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Randomized phase III trial (GORTEC 98-03

Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent

✍ Jacques Tortochaux; Yungan Tao; Elodie Tournay; Michel Lapeyre; Francois Lesauni 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Phase 1 Clinical Trial of Re-irradiation

Phase 1 Clinical Trial of Re-irradiation With Pemetrexed and Erlotinib Followed by Maintenance Erlotinib for Patients With Recurrent and Second Primary Squamous Cell Carcinoma of the Head and Neck

✍ Porosnicu, M.; Greven, K.M.; Sullivan, C.A.; Waltonen, J.D.; Rouchard, R. Plasse 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB